Edgewell Personal Care Co (EPC)
Official siteCONSUMER DEFENSIVE • HOUSEHOLD & PERSONAL PRODUCTS • NYSE
Market Cap: $1.26B
Last updated: Nov 17, 2026 at 11:05 AM ET
Edgewell Personal Care Co (EPC) Financials: Revenue, Profit and Cash Flow
Edgewell Personal Care reported revenue of $2.00B for the fiscal year ended Sep 30, 2026, up 1.8% from the year before. That year, net income was -$51.70M with a net margin of -2.6%, operating cash flow was $49.60M and free cash flow was -$10.00M. The quarter ended Sep 30, 2026 had revenue of $484.10M and net income of $10.90M.
Revenue and Margins
The operating margin was 2.1% in the fiscal year ended Sep 2026. Over the 9 years to Sep 2026, revenue fell from $2.30B, a compound annual decline of 1.5%.
| Fiscal year | Revenue | Growth | Gross margin | Operating margin | Net margin |
|---|---|---|---|---|---|
| Sep 2026 | $2.00B | +1.8% | 41.6% | 2.1% | -2.6% |
| Sep 2025 | $1.96B | -0.4% | 43.2% | 5.6% | 1.3% |
| Sep 2024 | $1.97B | -12.5% | 43.3% | 6.8% | 5.0% |
| Sep 2023 | $2.25B | +3.7% | 41.8% | 10.1% | 5.1% |
| Sep 2022 | $2.17B | +4.0% | 40.5% | 8.4% | 4.6% |
| Sep 2021 | $2.09B | +7.1% | 45.6% | 11.5% | 5.6% |
| Sep 2020 | $1.95B | -8.9% | 45.2% | 9.0% | 3.5% |
| Sep 2019 | $2.14B | -4.2% | 45.1% | 11.4% | -17.4% |
| Sep 2018 | $2.23B | -2.8% | 46.2% | 9.6% | 4.6% |
| Sep 2017 | $2.30B | N/A | 49.0% | 0.0% | 0.2% |
Income Statement
In the fiscal year ended Sep 2026, the company posted a net loss after a profit the year before. In the quarter ended Sep 2026, net income turned positive after a loss in the same quarter a year earlier.
Annual
| Line item | Sep 2026 | Sep 2025 | Sep 2024 | Sep 2023 | Sep 2022 | Sep 2021 | Sep 2020 | Sep 2019 | Sep 2018 | Sep 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.00B | $1.96B | $1.97B | $2.25B | $2.17B | $2.09B | $1.95B | $2.14B | $2.23B | $2.30B |
| Cost of revenue | $1.17B | $1.11B | $1.12B | $1.31B | $1.29B | $1.14B | $1.07B | $1.17B | $1.20B | $1.17B |
| Gross profit | $830.00M | $847.80M | $854.00M | $940.80M | $880.50M | $951.20M | $880.90M | $966.60M | $1.03B | $1.13B |
| Research and development | $57.50M | $55.60M | $56.40M | $58.50M | $55.50M | $57.80M | $55.30M | $53.50M | $61.10M | $67.60M |
| Operating income | $41.40M | $110.20M | $133.30M | $227.00M | $182.30M | $239.90M | $176.00M | $243.80M | $215.10M | -$1.10M |
| Net income | -$51.70M | $25.40M | $98.60M | $114.70M | $99.50M | $117.80M | $67.60M | -$372.20M | $103.30M | $5.70M |
| EBITDA | $145.90M | $199.20M | $219.40M | $317.60M | $285.40M | $328.20M | $263.50M | $336.10M | $329.40M | $110.70M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $484.10M | $570.10M | $519.50M | $422.80M | $600.50M | $560.40M | $516.60M | $415.10M | $517.60M | $647.80M | $599.40M | $488.90M |
| Gross profit | $209.60M | $242.50M | $216.90M | $161.00M | $227.70M | $250.10M | $236.90M | $172.50M | $212.80M | $287.10M | $258.10M | $197.70M |
| Operating income | $16.90M | $25.00M | $18.40M | -$18.90M | -$25.30M | $45.00M | $49.00M | $9.30M | $20.40M | $82.70M | $70.10M | $26.10M |
| Net income | $10.90M | $13.70M | -$10.60M | -$65.70M | -$30.60M | $29.10M | $29.00M | -$2.10M | $8.80M | $49.00M | $36.00M | $4.80M |
Balance Sheet
As of Sep 2026, total debt of $1.28B exceeded cash and equivalents by $908.70M.
Annual
| Line item | Sep 2026 | Sep 2025 | Sep 2024 | Sep 2023 | Sep 2022 | Sep 2021 | Sep 2020 | Sep 2019 | Sep 2018 | Sep 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $3.55B | $3.76B | $3.73B | $3.74B | $3.71B | $3.67B | $3.54B | $3.42B | $3.95B | $4.19B |
| Current assets | $1.12B | $995.50M | $936.00M | $962.40M | $942.20M | $1.14B | $983.60M | $1.04B | $951.20M | $1.19B |
| Cash and equivalents | $375.60M | $225.70M | $209.10M | $216.40M | $188.70M | $479.20M | $364.70M | $341.60M | $266.40M | $502.90M |
| Total liabilities | $2.08B | $2.20B | $2.15B | $2.20B | $2.25B | $2.09B | $2.11B | $2.12B | $2.21B | $2.45B |
| Short-term debt | $38.80M | $29.50M | $24.50M | $19.50M | $19.00M | $26.50M | $21.10M | $131.40M | $193.10M | $19.40M |
| Long-term debt | $1.25B | $1.38B | $1.27B | $1.36B | $1.39B | $1.23B | $1.24B | $1.10B | $1.10B | $1.53B |
| Shareholder equity | $1.47B | $1.55B | $1.58B | $1.54B | $1.47B | $1.58B | $1.43B | $1.30B | $1.74B | $1.74B |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $3.55B | $3.54B | $3.53B | $3.77B | $3.76B | $3.79B | $3.77B | $3.70B | $3.73B | $3.71B | $3.76B | $3.79B |
| Total liabilities | $2.08B | $2.08B | $2.09B | $2.28B | $2.20B | $2.23B | $2.26B | $2.20B | $2.15B | $2.13B | $2.21B | $2.24B |
| Cash and equivalents | $375.60M | $397.10M | $299.70M | $223.30M | $225.70M | $199.60M | $170.10M | $175.50M | $209.10M | $196.10M | $196.20M | $214.20M |
| Shareholder equity | $1.47B | $1.46B | $1.45B | $1.49B | $1.55B | $1.57B | $1.51B | $1.50B | $1.58B | $1.58B | $1.55B | $1.55B |
Cash Flow
In the fiscal year ended Sep 2026, capital expenditures exceeded operating cash flow, leaving negative free cash flow.
Annual
| Line item | Sep 2026 | Sep 2025 | Sep 2024 | Sep 2023 | Sep 2022 | Sep 2021 | Sep 2020 | Sep 2019 | Sep 2018 | Sep 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $49.60M | $118.40M | $231.00M | $216.10M | $102.00M | $229.00M | $232.60M | $190.60M | $259.40M | $313.60M |
| Capital expenditures | $59.60M | $77.00M | $56.50M | $49.50M | $56.40M | $56.80M | $47.70M | $58.00M | $62.00M | $69.00M |
| Free cash flow | -$10.00M | $41.40M | $174.50M | $166.60M | $45.60M | $172.20M | $184.90M | $132.60M | $197.40M | $244.60M |
| Dividends paid | $28.40M | $29.30M | $30.70M | $31.50M | $32.60M | $25.60M | $0 | $0 | $25.60M | $0 |
| Share repurchases | $15.80M | $90.20M | $58.50M | $75.20M | $125.30M | $9.20M | $0 | $0 | $124.40M | $165.40M |
| Investing cash flow | $289.20M | -$72.90M | -$62.40M | -$50.50M | -$355.40M | -$48.70M | -$196.40M | -$45.50M | -$118.80M | -$84.60M |
| Financing cash flow | -$182.80M | -$30.00M | -$179.40M | -$146.50M | -$17.60M | -$65.40M | -$18.70M | -$63.80M | -$379.60M | -$478.00M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $2.50M | $118.70M | $54.30M | -$125.90M | $74.10M | $114.80M | $45.10M | -$115.60M | $73.70M | $101.20M | $129.00M | -$72.90M |
| Capital expenditures | $18.40M | $15.60M | $14.00M | $11.60M | $27.60M | $15.50M | $17.10M | $16.80M | $25.90M | $12.60M | $11.50M | $6.50M |
| Free cash flow | -$15.90M | $103.10M | $40.30M | -$137.50M | $46.50M | $99.30M | $28.00M | -$132.40M | $47.80M | $88.60M | $117.50M | -$79.40M |
Frequently Asked Questions About EPC
What is Edgewell Personal Care's annual revenue?
Edgewell Personal Care reported revenue of $2.00B for the fiscal year ended Sep 30, 2026.
How fast is Edgewell Personal Care's revenue growing?
Revenue was up 1.8% for the fiscal year ended Sep 30, 2026 compared with the year before. The compound annual revenue growth rate over 3 years was -3.9%.
Is Edgewell Personal Care profitable?
No. Edgewell Personal Care reported net income of -$51.70M for the fiscal year ended Sep 30, 2026, with a net margin of -2.6%.
How much free cash flow does EPC generate?
For the fiscal year ended Sep 30, 2026, operating cash flow of $49.60M minus capital expenditures of $59.60M produced free cash flow of -$10.00M.
How much debt does Edgewell Personal Care have?
The balance sheet dated Sep 30, 2026 reported long-term debt of $1.25B, short-term debt of $38.80M and cash and equivalents of $375.60M.
EPC pages: Overview, Dividends, Earnings, Forecast, Financials, Valuation, Competitors